Zinc-mediated modulation of the configuration and activity of complexes between copper and amyloid-β peptides

Biochemical and Biophysical Research Communications

Volumn 417, Issue 1, 2012, Pages 153-156

  Liu, Lin ^a,b   Xia, Ning ^b  

^a ANYANG NORMAL UNIVERSITY   (China)

^b CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Alzheimer's disease; Amyloid ; Configuration and activity; Metal ions; Ternary complex

Indexed keywords

AMYLOID BETA PROTEIN; ASCORBIC ACID; COPPER; HYDROGEN PEROXIDE; ZINC;

ALZHEIMER DISEASE; ARTICLE; BINDING AFFINITY; CATALYSIS; ELECTROCHEMICAL ANALYSIS; FLUORESCENCE SPECTROSCOPY; NEUROMODULATION; NEUROPROTECTION; OXIDATION REDUCTION POTENTIAL; PRIORITY JOURNAL; REACTION TIME;

ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; CATALYSIS; COPPER; HUMANS; PEPTIDE FRAGMENTS; PROTEIN CONFORMATION; ZINC;

EID: 84855789122     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2011.11.074     Document Type: Article

References (29)

1. Hardy J., Selkoe D.J. Medicine - The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 2002, 297:353-356.
2. Varadarajan S., Yatin S., Aksenova M., et al. Review: Alzheimer's amyloid beta-peptide-associated free radical oxidative stress and neurotoxicity. J. Struct. Biol. 2000, 130:184-208.
3. Bush A.I. The metallobiology of Alzheimer's disease. Trends Neurosci. 2003, 26:207-214.
4. Liu G., Huang W., Moir R.D., et al. Metal exposure and Alzheimer's pathogenesis. J. Struct. Biol. 2006, 155:45-51.
5. J. Dong, J.E. Shokes, R.A. Scott, et al., Modulating amyloid self-assembly and fibril morphology with Zn(II). J. Am. Chem. Soc. (2006).
6. Faller P. Copper and zinc binding to amyloid-β: coordination, dynamics, aggregation, reactivity and metal-ion transfer. Chem. BioChem. 2009, 10:2837-2845.
7. Ha C., Ryu J., Park C.B. Metal ions differentially influence the aggregation and deposition of Alzheimer's β-amyloid on a solid template. Biochemistry 2007, 46:6118-6125.
8. Jakob-Roetne R., Jacobsen H. Alzheimer's disease: from pathology to therapeutic approaches. Angew. Chem. Int. Ed. 2009, 48:3030-3059.
9. 2+ in a mononuclear metal ion binding site. J. Am. Chem. Soc. 2004, 126:13534-13538.
10. I in a linear Bis-His coordination environment: insight into a possible neuroprotective mechanism for the amyloid-β peptide. J. Am. Chem. Soc. 2008, 130:17826-17835.
11. Sigel A., Sigel H., Sigel R.K.O. Metal Ions in Life Sciences 2006, John Wiley & Sons, West Sussex.
12. Syme C.D., Nadal R.C., Rigby S.E.J., et al. Copper binding to the amyloid-beta peptide associated with Alzheimer's disease. J. Biol. Chem. 2004, 279:18169-18177.
13. Lovell M.A., Robertson J.D., Teesdale W.J., et al. Copper, iron and zinc in Alzheimer's disease senile plaques. J. Neurol. Sci. 1998, 158:47-52.
14. Jiang D., Li X., Liu L., et al. Reaction rates and mechanism of the ascorbic acid oxidation by molecular oxygen facilitated by Cu(II)-Containing amyloid-β complexes and aggregates. J. Phys. Chem. B 2010, 114:4896-4903.
15. Drew S.C., Noble C.J., Masters C.L., et al. Pleomorphic copper coordination by Alzheimer's disease amyloid-beta peptide. J. Am. Chem. Soc. 2009, 131:1195-1207.
16. P. Faller, C. Hureau, Bioinorganic chemistry of copper and zinc ions coordinated to amyloid-β peptide. Dalton Trans. (2009) 1080-1094.
17. Maitti N.C., Jiang D., Wain A.J., et al. Mechanistic studies of Cu(II) binding to amyloid-β peptides and fluorescence and redox behaviors of the resulting complexes. J. Phys. Chem. B 2008, 112:8406-8411.
18. Hatcher L.Q., Hong L., Bush W.D., et al. Quantification of the binding constat of copper(II) to the Amyloid-Beta peptide. J. Phys. Chem. B 2008, 112:8160-8164.
19. Ma Q.-F., Hu J., Wu W.-H., et al. Characterization of copper binding to the peptide amyloid-beta(1-16) associated with Alzheimer's disease. Biopolymers 2006, 83:20-31.
20. Maiti N.C., Jiang D., Wain A.J., et al. Mechanistic studies of Cu(II) binding to amyloid-b peptides and fluorescence and redox behaviors of the resulting complexes. J. Phys. Chem. B 2008, 112:8406-8411.
21. Sarell C.J., Syme C.D., Rigby S.E.J., et al. Copper(II) binding to amyloid-β fibrils of Alzheimer's disease reveals a picomolar affinity: stoichiometry and coordination geometry are independent of Aβ oligomeric form. Biochemistry 2009, 48:4388-4402.
22. Tõugu V., Karafin A., Palumaa P. Binding of zinc(II) and copper(II) to the full-length Alzheimer's amyloid-beta peptide. J. Neurochem. 2008, 104:1249-1259.
23. 1-42. J. Neurochem. 2000, 75:1219-1233.
24. Guilloreau L., Damian L., Coppel Y., et al. Structural and thermodynamical properties of CuII amyloid-beta16/28 complexes associated with Alzheimer's disease J. Biol. Inorg. Chem. 2006, 11:1024-1038.
25. Clements A., Allsop D., Walsh D.M., et al. Aggregation and metal-binding properties of mutant forms of the amyloid Aβ peptide of Alzheimer's disease. J. Neurochem. 1996, 66:740-747.
26. Garzon-Rodriguez W., Yatsimirsky A.K., Glabe C.G. Binding of Zn(II), Cu(II), and Fe(II) ions to Alzheimer's all peptide studied by fluorescence. Bioorg. Med. Chem. Lett. 1999, 9:2243-2248.
27. 2+ among the available binding sites of Aβ(1-16)-polyethylenglycol-ylated peptide: implications in Alzheimer's disease. Inorg. Chem. 2011, 50:5342-5350.
28. Liu L., Jiang D., McDonald A., et al. Copper redox cycling in the prion protein depends critically on binding mode. J. Am. Chem. Soc. 2011, 133:12229-12237.
29. Que E.L., Domaille D.W., Chang C.J. Metals in neurobiology: probing their chemistry and biology with molecular imaging. Chem. Rev. 2008, 108:1517-1549.